What is the recommended frequency of Platelet-Rich Plasma (PRP) treatment for an adult patient with no significant medical history after a hair transplant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PRP Treatment Frequency After Hair Transplant

For patients undergoing hair transplant surgery, administer PRP as three intradermal scalp injections at the time of transplant (month 0), month 1, and month 3 post-transplant, followed by maintenance injections every 6 months indefinitely to sustain results. 1, 2

Initial Treatment Protocol Post-Transplant

The split scalp injection protocol specifically designed for hair transplant patients involves:

  • First injection: At the time of hair transplantation (month 0) 1
  • Second injection: One month after transplant 1
  • Third injection: Three months after transplant 1

This differs from the standard androgenetic alopecia protocol (which uses consecutive monthly sessions) because the surgical trauma of transplantation creates an optimal window for PRP to enhance follicle survival and integration. 3

Maintenance Phase

After completing the initial 3-session protocol, maintenance injections every 6 months are required to sustain results long-term. 2, 4 This is critical because discontinuation results in loss of gains—patients who stopped treatment experienced progressive hair loss starting at 12-16 months after their last injection. 5

Technical Administration Details

Each treatment session should deliver:

  • Volume: 5-7 mL PRP per session 1, 4
  • Needle: 30-gauge × 4 mm 4
  • Technique: Point-by-point injection at 90-degree angle, 2-4 mm depth, spacing injections 1 cm apart across mapped areas 4
  • Preparation: Use manual double-spin method targeting 1.0-1.5 million platelets per microliter 2
  • Activation: Do NOT activate PRP—nonactivated PRP demonstrates 31% greater increases in hair count and density 2, 4

Concurrent Therapy for Optimal Outcomes

The evidence strongly supports combination therapy rather than PRP alone:

  • Topical minoxidil 5%: Apply 1 mL twice daily throughout treatment and continue indefinitely 2, 4
  • Finasteride: Consider adding as background therapy, ideally starting 1 month before transplant 1, 6
  • The triple combination (PRP + minoxidil + finasteride) represents the most effective evidence-based approach 4, 6

Expected Timeline and Outcomes

When PRP is used with hair transplantation:

  • Immediate benefit: Preserving grafts in PRP before implantation increases graft uptake and hair thickness compared to saline preservation 3
  • 2-3 months: Initial improvements in hair density become visible 2, 4
  • 6 months: Hair density increases by 1.74 times and hair diameter by 14.3 times 2, 4
  • >75% hair regrowth: All participants in PRP-treated transplant groups achieved this by 6 months 3

Critical Pitfalls to Avoid

Do not use activated PRP—activation reduces efficacy by 31% compared to nonactivated preparations. 2, 4

Do not skip maintenance injections—four patients who discontinued treatment after initial success experienced relapse at 12-16 months, requiring re-treatment. 5

Do not use PRP as monotherapy—combination with topical minoxidil 5% is significantly more effective than PRP alone. 2, 4

Emerging Alternative: PRF

Platelet-rich fibrin (PRF) is emerging as a potentially superior alternative with theoretical advantages including lower cost and easier preparation, while maintaining similar efficacy and safety profile. 2, 4 The same timing protocol applies if using PRF instead of PRP. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Platelet-Rich Plasma (PRP) Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

PRP for Hair Loss: Evidence-Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Finasteride Therapy for Hair Transplant Optimization

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended treatment protocol for Platelet-Rich Plasma (PRP) therapy for hair loss?
How does age, sex, and comorbidities (presence of additional diseases) affect response to Platelet-rich plasma (PRP) therapy for hair restoration?
What is the role of Platelet-Rich Plasma (PRP) therapy in treating hair loss, specifically androgenetic alopecia?
What is the comparison between platelet-rich plasma (PRP) and exosome therapy for hair regrowth?
What is the comparison between Platelet Rich Fibrin (PRF) and Growth Factor Concentrate (GFC) for hair regeneration?
Can tinea corporis (ringworm of the body) resemble psoriasis vulgaris or pityriasis rubra pilaris (PRP) histopathologically?
What does an isolated gamma-glutamyl transferase (GGT) increase in liver function tests indicate in a young adult patient with a recent diagnosis of hepatitis A?
What is the recommended management for a patient with influenza and prolonged fever, particularly those with underlying medical conditions or compromised immune systems?
When can a pediatric patient with tinea capitis expect hair regrowth to begin after being switched to itraconazole (antifungal medication) from griseofulvin and ketoconazole (antifungal medication) shampoo?
What does an elevated monocyte (white blood cell type) count with a normal white blood cell count indicate in a patient?
When can a child with a history of tinea capitis, previously treated with griseofulvin and ketoconazole (antifungal) shampoo, expect their hair to grow back after starting itraconazole (antifungal) treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.